Armando had Stage 4 metastatic urothelial carcinoma (mUC), also known as advanced bladder cancer. Bladder cancer is a serious ...

A population-based study revealed treatment patterns among patients starting chemotherapy as first-line therapy for ...

Some patients with low-grade Ta nonmuscle-invasive bladder cancer (LG Ta NMIBC) can experience recurrence after many years.

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Discover recent advancements in near-infrared fluorescence imaging that have revolutionised lymph node tracing in cancers such as breast and penile cancers.

A woman undergoing treatment for cancer took a dip in the Ganga river, hoping the auspicious occasion of Mauni Amavasya turns ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on the rise. In Thailand, it is the 4th most common cancer among men (1), ...

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

Pfizer’s GU portfolio includes seven approved medicines across bladder ... in patients with metastatic castration-resistant prostate cancer (mCRPC), which will be featured in ASCO GU’s ...

A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for ...

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve overall survival in patients with advanced of metastatic non-small cell lung ...